Joia Mukherjee
Joia Mukherjee, MD, MPH
Senior Clinical and Academic Advisor, Partners In Health
Dr. Joia Mukherjee, MD, MPH is an internist, pediatrician, public health and infectious disease specialist, author, human rights advocate, and an associate professor at Harvard Medical School. Dr. Mukherjee advises colleagues around the world on providing preventive and curative health care and linking social programs to health care efforts in in Haiti, Rwanda, Lesotho, Malawi, Sierra Leone, Liberia, Peru, and Kazakhstan. In the COVID-19 pandemic, she supported states and cities across the United States in their efforts to combat the virus. Because of her global health expertise—in HIV, tuberculosis, and Ebola, and most recently her global and US-based work in COVID-19 — she has been interviewed in print, broadcast, and other digital media.
Dr. Mukherjee is committed to the mentorship of the next generation of clinicians in the US and abroad. She is a productive scholar with an h-index of 54. She is the Director and Advisory Dean of the F.W. Peabody Society at Harvard Medical School. Dr. Mukherjee directs the master’s degree program in Global Health Delivery at HMS, where she trains clinicians and scholars from across the globe to design, evaluate, and implement systems to deliver high-quality health care. She is the author of the widely used text book, An Introduction to Global Health Delivery: Practice, Equity, Human Rights (Oxford University Press), the second edition published in 2021. Because of her expertise in infectious diseases, health systems, and social justice, she serves on the board of directors of Village Health Works (Burundi), Project Muso (Mali), Institute for Justice & Democracy (US and Haiti), and advises a number of grassroots medical organizations in their efforts to deliver health care with a human rights approach to poor communities across the globe. Dr. Mukherjee also consults for the World Health Organization and other international agencies on health system strengthening, human resources for health, treatment for HIV, hepatitis C, drug-resistant tuberculosis, and COVID-19.